Emil Kendziorra, the co-founder and CEO of cryonics provider Tomorrow Biostasis, presents report on quality of Tomorrow Bio's cryopreservation cases done in 2025.
Some important highlights:
- why public quality reports matter
- the mindset about handling issues during cryopreservation
- quality of cases in USA in particular
- recalibration on CT scanes based on pig tests
- electron microscopy quality tests of vitrified brain tissue (more in a dedicated webinar)
- big change on 18th February 2026
- Q&A
0 Comments
No comments yet.